MacroGenics reported $37.25M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
AbbVie USD 69.89B 2.74B Mar/2025
Amgen USD 56.2B 1.18B Jun/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Biogen USD 6.59B 296.8M Jun/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Daiichi Sankyo JPY 101.33B 97M Mar/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
Genmab DKK 148M 5M Jun/2025
Geron USD 121.84M 3.12M Jun/2025
Gilead Sciences USD 24.95B 6M Jun/2025
J&J USD 52.25B 15.62B Mar/2025
MacroGenics USD 37.25M 37.25M Jun/2025
Merck USD 34.84B 2.27B Mar/2025
Pfizer USD 60.93B 1.18B Jun/2025
Regeneron Pharmaceuticals USD 2.71B 300K Jun/2025
Roche Holding CHF 34.44B 5.23B Jun/2024
Xencor USD 67.93M 86.45M Jun/2025